Loading clinical trials...
Loading clinical trials...
Over the last two decades, the number of patients with hematological malignancies (HMs) admitted to the ICU increased and their mortality has dropped sharply. Patients with HMs increasingly require ad...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Grenoble
NCT05417971 · Hematologic Malignancy
NCT05735717 · Hematologic Malignancy, Acute Leukemia, and more
NCT05529069 · Mantle Cell Lymphoma, Non Hodgkin Lymphoma, and more
NCT07468006 · Respiratory Insufficiency in Children
NCT07257419 · Relapsed Pediatric ALL, Hematopoietic Cell Transplantation, and more
Hematologic unit - Hospital Grenoble Alpes
Grenoble
Intensive Care Unit - Hospital Grenoble-Alpes
Grenoble
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions